Department of Health
and Human Services (HHS)
and Human Services (HHS)
September 29, 2021
PAR-20-316 - NIH Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 - Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke (NINDS)
National Eye Institute (NEI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
This notice is to alert potential applicants to the early expiration of Funding Opportunity Announcement (FOA) PAR-20-316 "NIH Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 - Clinical Trial Optional)". Effective immediately, the remaining receipt dates for this FOA have been cancelled. This FOA will expire October 1, 2021.
The following section of PAR-20-316 has therefore been modified:
Currently Reads:
Part 1. Overview Information
Key Dates
| Application Due Date(s) |
September 14, 2021, September 13, 2022, September 12, 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | February 2022; February 2023; February 2024 |
| Advisory Council Review | May 2022; May 2023; May 2024 |
| Advisory Council Review | July 2022; July 2023; July 2024 |
| Expiration Date | September 13, 2023 |
Modified to Read (key change shown in bold italics to indicate early expiration and removal of remaining receipt dates):
Part 1. Overview Information
Key Dates
| Application Due Date(s) |
September 14, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | February 2022 |
| Advisory Council Review | May 2022 |
| Advisory Council Review | July 2022 |
| Expiration Date | October 1, 2021 |
All other aspects of this FOA remain unchanged.
David A. Jett, Ph.D.
National Institute of Neurological Disorder and Stroke (NINDS)
Telephone: 301-496-6035
Email: [email protected]